UZEDY
LIVE

Serial Number

79456733

Owner

Teva Pharmaceuticals International GmbH

Filing Date

May 27, 2026

Add to watchlist:

No watchlists yet
View on USPTO

UZEDY Trademark

Serial Number: 79456733

UZEDY is a trademark filed by Teva Pharmaceuticals International GmbH on May 27, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Teva Pharmaceuticals International GmbH (109 trademarks)

Schlüsselstrasse 12

Entity Type: 98

Trademark Details

Filing Date

May 27, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of depression; pharmaceutical preparations for the prevention and treatment of psychological disorders; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of osteoporosis; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; pharmaceutical preparations for the prevention and treatment of aids-related disorders; pharmaceutical preparations that support, encourage and promote bone strength; pharmaceutical preparations that support, encourage and promote bone health; pharmaceutical preparations used in the treatment of bone disorders and bone diseases; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, fertility enhancement preparations; pharmaceutical preparations, namely, hormone replacement therapy preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical agents affecting the central nervous system; pharmaceutical agents affecting circulatory systems; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting urogenital organs; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of neurological disorders.

Filing History

SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 20, 2026 REPR